Jonathan W. Uhr
About
In The Last Decade
Jonathan W. Uhr
183 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Immunology 5.5k
- Oncology 4.5k
- Molecular Biology 4.3k
- Radiology, Nuclear Medicine and Imaging 3.3k
- Cancer Research 2.5k
Countries citing papers authored by Jonathan W. Uhr
This map shows the geographic impact of Jonathan W. Uhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Uhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Uhr more than expected).
Fields of papers citing papers by Jonathan W. Uhr
This network shows the impact of papers produced by Jonathan W. Uhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Uhr. The network helps show where Jonathan W. Uhr may publish in the future.
Co-authorship network of co-authors of Jonathan W. Uhr
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Uhr. A scholar is included among the top collaborators of Jonathan W. Uhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Uhr. Jonathan W. Uhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 150 | |
| 2 | Patterned nanomagnets on-chip for screening circulating tumor cells in blood | 2 |
| 3 | 167 | |
| 4 | Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases breakdown → | 2015 |
| 5 | Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. | 241 |
| 6 | Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo. | 138 |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 37 | |
| 10 | 22 | |
| 11 | 127 | |
| 12 | 100 | |
| 13 | CELL SURFACE IMMUNOGLOBULIN breakdown → | 335 |
| 14 | 86 | |
| 15 | 87 | |
| 16 | 8 | |
| 17 | 60 | |
| 18 | 45 | |
| 19 | 153 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.